| 王永杰,许红,俞亚静,李菁.药品集中带量采购背景下芜湖市第一人民医院ARB类降压药使用情况分析[J].中国药事,2022,36(3):355-362 |
| 药品集中带量采购背景下芜湖市第一人民医院ARB类降压药使用情况分析 |
| Analysis on the Use of ARB Anti-hypertensive Drugs in Wuhu No. 1 People's Hospital Under the Background of Centralized Drug Procurement |
| |
| DOI：10.16153/j.1002-7777.2022.03.017 |
| 中文关键词: 药品集中采购 抗高血压药 血管紧张素Ⅱ受体阻滞剂 医保支付标准 |
| 英文关键词: centralized procurement of drugs anti-hypertensive drugs angiotensin Ⅱ receptor blocker standard of medical insurance payment |
| 基金项目: |
|
| 摘要点击次数: 813 |
| 全文下载次数: 259 |
| 中文摘要: |
| 目的：分析第一、第二批国家药品集中采购后对芜湖市第一人民医院血管紧张素Ⅱ受体阻滞剂 (AngiotensinⅡ Receptor Blocker, ARB)类降压药使用的影响，为更好地执行国家药品集中采购政策提供参考。方法：汇总芜湖市第一人民医院第一批国家集中带量采购实施后一年内(即2020年01月01日至 2020年12月31日)门诊的用药数据和带量采购实施前同期门诊的用药数据(即2019年01月01日至2019年 12月31日)，比较药品的价格、生产企业、销售金额、消耗量等，采用药物经济学方法回顾性分析执行前后的使用数量、使用金额、用药频度(DDDs)、限定日费用(DDDc)等。结果：国家药品集中采购政策实施后，门诊口服ARB类抗高血压药物使用量同比增加28.54%，使用金额降低10.19%。纳入集中采购的5种通用名的药品使用数量同比增加19.65%，使用金额同比减少51.65%，节省费用185万余元。结论：国家药品集中采购政策切实降低了患者的用药负担，政府应及时完善医保支付标准建设。 |
| 英文摘要: |
| Objective：To analyze the impact on the use of ARB anti-hypertensive drugs in Wuhu No. 1 People's Hospital after the first and second batches of national centralized drug procurement in order to provide references for the better implementation of national drug centralized procurement policy. Methods：The medication data from the outpatient department of Wuhu No. 1 People's Hospital, including drug prices, manufacturers, sales amounts, consumption, etc. within a year after the implementation of the first batch of national centralized procurement(January 1st, 2020 to December 31, 2020)and the corresponding period before the implementation of centralized procurement (January 1st, 2019 to December 31，2019)were summarized and compared. The pharmacoeconomics methods were used to retrospectively analyze the utilization numbers, the total cost, the defined daily dose (DDDs), the defined daily cost(DDDC)and other data before and after the implementation. Results: After the implementation of the national drug centralized procurement policy, the use of oral ARB antihypertensive drugs in the outpatient department has increased by 28.54% year-on-year, and the consumption sum has decreased by 10.19%. The use of the five generic drugs included in centralized procurement has increased by 19.65% year-on-year, and the consumption sum has decreased by 51.65% year-on-year, saving more than RMB 1.85 million. Conclusion：The national drug centralized procurement policy has effectively reduced the economic burden of patients. The government should improve the medical insurance payment standards in time. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|